This decommissioned ERA site remains active temporarily to support our final migration steps to https://ualberta.scholaris.ca, ERA's new home. All new collections and items, including Spring 2025 theses, are at that site. For assistance, please contact erahelp@ualberta.ca.
Search
Skip to Search Results-
Spring 2014
Gene delivery is an emerging therapy for treatment of many different diseases and conditions, with the first therapy recently approved for clinical use. This thesis investigates non-viral carriers for gene delivery for bone regeneration, with an emphasis on the mechanisms of plasmid DNA (pDNA)...
-
Spring 2017
BCR-ABL fusion oncogene is the main driver mutation of Chronic Myeloid Leukemia (CML) that controls initiation, maintenance and progression to more aggressive stages of the disease. Current therapies with tyrosine kinase inhibitors in CML involve certain limitations, such as drug resistance and...